肠道炎症在肥胖和胰岛素抵抗中的早期作用。
Role of intestinal inflammation as an early event in obesity and insulin resistance.
机构信息
Department of Cell and Molecular Physiology, Center for Gastrointestinal Biology and Disease University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7574, USA.
出版信息
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):328-33. doi: 10.1097/MCO.0b013e3283478727.
Abstract
PURPOSE OF REVIEW
To highlight recent evidence supporting a concept that intestinal inflammation is a mediator or contributor to development of obesity and insulin resistance.
RECENT FINDINGS
Current views suggest that obesity-associated systemic and adipose tissue inflammation promote insulin resistance, which underlies many obesity-linked health risks. Diet-induced changes in gut microbiota also contribute to obesity. Recent findings support a concept that high-fat diet and bacteria interact to promote early inflammatory changes in the small intestine that contribute to development of or susceptibility to obesity and insulin resistance. This review summarizes the evidence supporting a role of intestinal inflammation in diet-induced obesity and insulin resistance and discusses mechanisms.
SUMMARY
The role of diet-induced intestinal inflammation as an early biomarker and mediator of obesity, and insulin resistance warrants further study.
摘要
目的综述
强调近期支持肠道炎症是肥胖和胰岛素抵抗发展的介质或促成因素的证据。
最新发现
目前的观点表明，肥胖相关的全身和脂肪组织炎症会促进胰岛素抵抗，这是许多与肥胖相关的健康风险的基础。饮食引起的肠道菌群变化也会导致肥胖。最近的研究结果支持这样一种观点，即高脂肪饮食和细菌相互作用，促进小肠的早期炎症变化，从而导致肥胖和胰岛素抵抗的发生或易感性。本综述总结了支持肠道炎症在饮食诱导的肥胖和胰岛素抵抗中的作用的证据，并讨论了相关机制。
总结
饮食诱导的肠道炎症作为肥胖和胰岛素抵抗的早期生物标志物和介质的作用值得进一步研究。
相似文献
1
Role of intestinal inflammation as an early event in obesity and insulin resistance.
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):328-33. doi: 10.1097/MCO.0b013e3283478727.
2
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.
PLoS One. 2010 Aug 16;5(8):e12191. doi: 10.1371/journal.pone.0012191.
3
High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.
J Physiol. 2019 Jun;597(12):3029-3051. doi: 10.1113/JP277353. Epub 2019 May 13.
4
Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Rev Invest Clin. 2014 Sep-Oct;66(5):450-9.
5
Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.
Physiology (Bethesda). 2016 Jul;31(4):283-93. doi: 10.1152/physiol.00041.2015.
6
Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
Diabetes Metab Res Rev. 2015 Sep;31(6):545-61. doi: 10.1002/dmrr.2617. Epub 2014 Dec 8.
7
Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.
Nutr Res Rev. 2018 Dec;31(2):153-163. doi: 10.1017/S0954422417000269. Epub 2018 Jan 24.
8
Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice.
PLoS One. 2011;6(6):e20944. doi: 10.1371/journal.pone.0020944. Epub 2011 Jun 9.
9
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation.
Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G440-8. doi: 10.1152/ajpgi.00098.2010. Epub 2010 May 27.
10
[Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Med Sci (Paris). 2016 May;32(5):461-9. doi: 10.1051/medsci/20163205012. Epub 2016 May 25.
引用本文的文献
1
High-fat diet may increase the risk of insulin resistance by inducing dysbiosis.
Metabol Open. 2025 Jul 22;27:100381. doi: 10.1016/j.metop.2025.100381. eCollection 2025 Sep.
2
Lipid-associated macrophages are more abundant in subcutaneous than visceral adipose tissue in patients with obesity.
Obesity (Silver Spring). 2025 Aug;33(8):1543-1554. doi: 10.1002/oby.24323. Epub 2025 Jun 29.
3
Electroacupuncture modulates the gut-brain axis via the PI3K/Akt pathway to improve feeding behavior, body weight, glucolipid metabolism, and reduce insulin resistance in T2DM rats.
Diabetol Metab Syndr. 2025 Apr 9;17(1):122. doi: 10.1186/s13098-025-01683-y.
4
Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review.
Int J Mol Sci. 2025 Jan 20;26(2):862. doi: 10.3390/ijms26020862.
5
Obesity-associated memory impairment and neuroinflammation precede widespread peripheral perturbations in aged rats.
Immun Ageing. 2025 Jan 3;22(1):2. doi: 10.1186/s12979-024-00496-3.
6
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes.
Pharmaceuticals (Basel). 2024 Sep 28;17(10):1291. doi: 10.3390/ph17101291.
7
Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health.
Nutrients. 2024 Sep 19;16(18):3170. doi: 10.3390/nu16183170.
8
Gene expression alterations of purinergic signaling components in obesity-associated intestinal low-grade inflammation in type 2 diabetes.
Purinergic Signal. 2024 Dec;20(6):629-643. doi: 10.1007/s11302-024-10006-1. Epub 2024 Apr 8.
9
Incidence of Colorectal Cancer After Intestinal Infection Due to .
World J Oncol. 2024 Apr;15(2):279-286. doi: 10.14740/wjon1802. Epub 2024 Mar 21.
10
Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes.
Cell Mol Life Sci. 2024 Feb 5;81(1):77. doi: 10.1007/s00018-024-05124-3.
本文引用的文献
1
Intestinal microbiota in inflammation and insulin resistance: relevance to humans.
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. doi: 10.1097/MCO.0b013e328347924a.
2
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer.
Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):224-38. doi: 10.1038/nrgastro.2011.23. Epub 2011 Mar 8.
3
Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin.
Physiol Behav. 2011 Nov 30;105(1):100-5. doi: 10.1016/j.physbeh.2011.02.040. Epub 2011 Mar 2.
4
Type 2 diabetes as an inflammatory disease.
Nat Rev Immunol. 2011 Feb;11(2):98-107. doi: 10.1038/nri2925. Epub 2011 Jan 14.
5
Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
Annu Rev Med. 2011;62:361-80. doi: 10.1146/annurev-med-012510-175505.
6
Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis.
Am J Clin Nutr. 2011 Feb;93(2):234-42. doi: 10.3945/ajcn.110.002683. Epub 2010 Dec 8.
7
A Western diet increases serotonin availability in rat small intestine.
Endocrinology. 2011 Jan;152(1):36-47. doi: 10.1210/en.2010-0377. Epub 2010 Nov 10.
8
Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function.
Aliment Pharmacol Ther. 2010 Dec;32(11-12):1307-14. doi: 10.1111/j.1365-2036.2010.04475.x. Epub 2010 Sep 29.
9
Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota.
Gut. 2010 Nov;59(11):1476-84. doi: 10.1136/gut.2010.211706.
10
Relationship between severe obesity and gut inflammation in children: what's next?
Ital J Pediatr. 2010 Oct 1;36:66. doi: 10.1186/1824-7288-36-66.
Zotero 插件